Creative Medical Technology Holdings, Inc. (CELZ)
Creative Medical Technology Holdings, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Phoenix, AZ, US. The stock last traded at $1.18, down 4.84% on the session, giving a market capitalisation of $3.0M. On trailing twelve-month figures it carries a trailing P/E of -0.59, a net margin of -201355.4%. Its beta of 1.88 implies it has historically moved more than the broad market.
Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology. Among its therapeutic offerings are CaverStem, designed to address erectile dysfunction; FemCelz, which aims to restore genital sensitivity and alleviate dryness; StemSpine, developed to treat chronic lower back pain; ImmCelz, intended for stroke patients; and OvaStem, a solution for female infertility.
Creative Medical Technology Holdings, Inc. is most often compared with the following Healthcare names: